World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
90
Citations
33848
World Ranking
2415
National Ranking
1282

Overview

Weida Tong is affiliated with the National Center for Toxicological Research in the United States. Their research primarily focuses on the intersection of biochemistry, genetics, and molecular biology, with a strong emphasis on molecular biology, computational theory and mathematics, cancer research, pharmacology, and genetics.

The scientist's work spans several main topics, including:

  • Computational Drug Discovery Methods
  • Molecular Biology Techniques and Applications
  • Cancer Genomics and Diagnostics
  • Gene expression and cancer classification
  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmacogenetics and Drug Metabolism
  • Genomics and Rare Diseases

Weida Tong has contributed to numerous publications that appear frequently in recognized venues. The most common publication outlets include:

  • Drug Discovery Today
  • Genome biology
  • Chemical Research in Toxicology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Artificial Intelligence

Among the recent papers associated with Weida Tong are the following:

  • Transparency and reproducibility in artificial intelligence, 2020, Nature
  • Reporting guidelines for human microbiome research: the STORMS checklist, 2021, Nature Medicine
  • Regulatory landscape of nanotechnology and nanoplastics from a global perspective, 2021, Regulatory Toxicology and Pharmacology
  • Regulatory landscape of dietary supplements and herbal medicines from a global perspective, 2020, Regulatory Toxicology and Pharmacology
  • Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology, 2021, Nature Biotechnology

The scientist frequently collaborates with colleagues in their field. Notable co-authors include Joshua Xu, Huixiao Hong, Ruth Roberts, Leihong Wu, and Shraddha Thakkar.

Best Publications

  • The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

    Leming Shi;Laura H. Reid;Wendell D. Jones;Richard Shippy

  • The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

    Leming Shi;Gregory Campbell;Wendell D. Jones;Fabien Campagne

  • A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium

    Zhenqiang Su;Paweł P. Łabaj;Sheng Li;Jean Thierry-Mieg

  • The Estrogen Receptor Relative Binding Affinities of 188 Natural and Xenochemicals: Structural Diversity of Ligands

    Robert M. Blair;Hong Fang;William S. Branham;Bruce S. Hass

  • Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52.

    Tatiana I. Netzeva;Andrew P. Worth;Tom Aldenberg;Romualdo Benigni

  • Performance comparison of one-color and two-color platforms within the Microarray Quality Control (MAQC) project

    Tucker A Patterson;Edward K Lobenhofer;Stephanie B Fulmer-Smentek;Patrick J Collins

  • Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens.

    Hong Fang;Weida Tong;Leming M. Shi;Robert Blair

  • The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance

    Charles Wang;Binsheng Gong;Pierre R. Bushel;Jean Thierry-Mieg

  • Toward interoperable bioscience data

    Susanna-Assunta Sansone;Philippe Rocca-Serra;Dawn Field;Eamonn Maguire

  • Rat toxicogenomic study reveals analytical consistency across microarray platforms

    Lei Guo;Edward K Lobenhofer;Charles Wang;Richard Shippy

  • Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor.

    Hong Fang;Weida Tong;William S. Branham;Carrie L. Moland

  • Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.

    Wenqian Zhang;Ying Yu;Falk Hertwig;Falk Hertwig;Jean Thierry-Mieg

  • QSAR models using a large diverse set of estrogens

    Leming M. Shi;Hong Fang;Weida Tong;Jie Wu

  • FDA-approved drug labeling for the study of drug-induced liver injury.

    Minjun Chen;Vikrant Vijay;Qiang Shi;Zhichao Liu

  • The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies

    Leming Shi;Wendell D. Jones;Roderick V. Jensen;Stephen C. Harris

  • ISA software suite

    Philippe Rocca-Serra;Marco Brandizi;Eamonn Maguire;Eamonn Maguire;Nataliya Sklyar

  • A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages.

    Ying Yu;James C. Fuscoe;Chen Zhao;Chao Guo

  • High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury†‡§¶

    Minjun Chen;Jürgen Borlak;Weida Tong

  • A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data

    J. Luo;M. Schumacher;A. Scherer;D. Sanoudou

  • Quantitative structure‐activity relationship methods: Perspectives on drug discovery and toxicology

    Roger Perkins;Hong Fang;Weida Tong;William J. Welsh

Frequent Co-Authors

Huixiao Hong
Huixiao Hong United States Food and Drug Administration
Hong Fang
Hong Fang National Center for Toxicological Research
Leming Shi
Leming Shi Fudan University
Roger Perkins
Roger Perkins United States Food and Drug Administration
Lei Guo
Lei Guo National Center for Toxicological Research
Xiaowei Xu
Xiaowei Xu University of Arkansas at Little Rock
Pierre R. Bushel
Pierre R. Bushel National Institutes of Health
Cesare Furlanello
Cesare Furlanello Fondazione Bruno Kessler
Ruili Huang
Ruili Huang National Institutes of Health
Yuri Nikolsky
Yuri Nikolsky F1 Genomics

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your studies in Biology and Biochemistry can open doors to advanced and specialized healthcare careers. Many students now pursue online degrees, offering the flexibility to balance studies with work or other commitments.

For those interested in nursing leadership without direct clinical requirements, there are online dnp programs without clinicals that can prepare you for executive roles in healthcare. If your interests align with the administrative and research side of health sciences, an online phd in healthcare management helps develop critical skills for managing hospitals or leading policy initiatives.

The pharmaceutical sector is another popular pathway. Comprehensive online pharmacy programs equip students with advanced drug knowledge and open up clinical, research, and industry opportunities.

Additionally, exercise science is an emerging field closely related to biology, focusing on human health and performance. Earning an exercise science degree online accredited can lead to careers in fitness, rehabilitation, or sports science.

These online educational paths support diverse career trajectories while allowing you to build upon your foundational knowledge in biology and biochemistry.

Best Scientists Citing Weida Tong

Trending Scientists

Recently Published Articles